A detailed history of Morgan Stanley transactions in Care Dx, Inc. stock. As of the latest transaction made, Morgan Stanley holds 932,617 shares of CDNA stock, worth $12.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
932,617
Previous 1,578,228 40.91%
Holding current value
$12.1 Million
Previous $18.9 Million 47.85%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$7.96 - $12.37 $5.14 Million - $7.99 Million
-645,611 Reduced 40.91%
932,617 $9.88 Million
Q4 2023

Feb 13, 2024

BUY
$4.9 - $12.86 $4.4 Million - $11.5 Million
897,839 Added 131.96%
1,578,228 $18.9 Million
Q3 2023

Nov 15, 2023

SELL
$7.0 - $11.26 $2.22 Million - $3.57 Million
-317,033 Reduced 31.79%
680,389 $4.76 Million
Q2 2023

Aug 14, 2023

SELL
$7.61 - $9.46 $865,074 - $1.08 Million
-113,676 Reduced 10.23%
997,422 $8.48 Million
Q1 2023

May 15, 2023

BUY
$8.83 - $17.61 $6.27 Million - $12.5 Million
710,386 Added 177.28%
1,111,098 $10.2 Million
Q4 2022

Feb 14, 2023

BUY
$10.88 - $20.05 $1.96 Million - $3.61 Million
179,949 Added 81.51%
400,712 $4.57 Million
Q3 2022

Nov 14, 2022

SELL
$16.06 - $26.39 $3.47 Million - $5.71 Million
-216,315 Reduced 49.49%
220,763 $3.76 Million
Q2 2022

Oct 27, 2022

SELL
$20.49 - $39.72 $10.1 Million - $19.6 Million
-493,686 Reduced 53.04%
437,078 $9.39 Million
Q2 2022

Aug 15, 2022

SELL
$20.49 - $39.72 $10.1 Million - $19.6 Million
-493,686 Reduced 53.04%
437,078 $9.39 Million
Q1 2022

Oct 27, 2022

BUY
$28.19 - $46.6 $13.9 Million - $23 Million
493,686 Added 112.95%
930,764 $34.4 Million
Q1 2022

May 13, 2022

BUY
$28.19 - $46.6 $9.3 Million - $15.4 Million
329,981 Added 54.93%
930,764 $34.4 Million
Q4 2021

Feb 14, 2022

SELL
$41.2 - $73.6 $10.3 Million - $18.4 Million
-249,501 Reduced 29.34%
600,783 $27.3 Million
Q3 2021

Nov 15, 2021

BUY
$59.15 - $91.99 $50.3 Million - $78.2 Million
850,284 New
850,284 $53.9 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $695M
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.